Sylvaine F. A. Bruggraber

ORCID: 0000-0002-4844-8168
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Iron Metabolism and Disorders
  • Diabetes and associated disorders
  • Trace Elements in Health
  • Pancreatic function and diabetes
  • Diabetes Management and Research
  • Plant Micronutrient Interactions and Effects
  • Folate and B Vitamins Research
  • Hemoglobinopathies and Related Disorders
  • Heavy Metal Exposure and Toxicity
  • Breastfeeding Practices and Influences
  • Parathyroid Disorders and Treatments
  • Fibroblast Growth Factor Research
  • Child Nutrition and Water Access
  • Biochemical Acid Research Studies
  • Liver Diseases and Immunity
  • Infant Nutrition and Health
  • Digestive system and related health
  • Collagen: Extraction and Characterization
  • Microbial Applications in Construction Materials
  • Blood Pressure and Hypertension Studies
  • Cleft Lip and Palate Research
  • Phytase and its Applications
  • Sodium Intake and Health
  • Alcoholism and Thiamine Deficiency
  • Hydrogen's biological and therapeutic effects

University of Cambridge
2017-2024

MRC Human Nutrition Research
2004-2019

Medical Research Council
2013-2017

William Harvey Research Institute
2017

Queen Mary University of London
2017

Cambridge Research Biochemicals (United Kingdom)
2017

Wingate Institute
2004

University of California, Davis
2003

Iron deficiency is the most common nutritional disorder worldwide with substantial impact on health and economy. Current treatments predominantly rely soluble iron which adversely affects gastrointestinal tract. We have developed organic acid-modified Fe(III) oxo-hydroxide nanomaterials, here termed nano Fe(III), as alternative safe delivery agents. Nano absorption in humans correlated serum increase (P < 0.0001) direct vitro cellular uptake = 0.001), but not gastric solubility. The...

10.1016/j.nano.2014.06.012 article EN cc-by Nanomedicine Nanotechnology Biology and Medicine 2014-06-28

Exposure to persistent engineered nano and micro particles via the oral route is well established. Animal studies have demonstrated that, once ingested, a small proportion of such translocate from gastrointestinal tract other tissues. titanium dioxide widespread route, but only one study has provided indirect evidence (total analyses) absorption into blood stream in humans. We sought replicate these observations provide additional for particulate uptake.Human volunteers with normal...

10.1186/s12989-015-0101-9 article EN cc-by Particle and Fibre Toxicology 2015-09-01

The 2-5 nm Fe(III) oxo-hydroxide core of ferritin is less ordered and readily bioavailable compared to its pure synthetic analogue, ferrihydrite. We report the facile synthesis tartrate-modified, nano-disperse ferrihydrite small primary particle size, but with enlarged or strained lattice structure (~2.7Å for main Bragg peak versus 2.6Å ferrihydrite). Analysis indicated that co-precipitation conditions can be achieved tartrate inclusion into developing particles, retarding both growth...

10.1016/j.nano.2013.12.011 article EN cc-by-nc-sa Nanomedicine Nanotechnology Biology and Medicine 2014-01-04

High dietary sodium intake triggers increased blood pressure (BP). Animal studies show that salt loading results in dermal Na+ accumulation and lymphangiogenesis mediated by VEGF-C (vascular endothelial growth factor C), both attenuating the rise BP. Our objective was to determine whether these mechanisms function humans. We assessed skin electrolytes, BP, plasma 48 healthy participants randomized placebo (70 mmol sodium/d) slow (200 mmol/d) for 7 days. Skin K+ concentrations were measured...

10.1161/hypertensionaha.117.10003 article EN cc-by Hypertension 2017-10-04

Abstract Aims Heterogeneity in the rate of β ‐cell loss newly diagnosed type 1 diabetes patients is poorly understood and creates a barrier to designing interpreting disease‐modifying clinical trials. Integrative analyses baseline multi‐omics data obtained after diagnosis may provide mechanistic insight into diverse rates disease progression diagnosis. Methods We collected samples pan‐European consortium that enabled concerted analysis five different omics modalities from 97 patients. In...

10.1002/dmrr.3833 article EN cc-by-nc-nd Diabetes/Metabolism Research and Reviews 2024-07-01

Dietary non-heme iron contains ferrous [Fe(II)] and ferric [Fe(III)] fractions the latter should hydrolyze, forming Fe(III) oxo-hydroxide particles, on passing from acidic stomach to less duodenum. Using conditions mimic in vivo hydrolytic environment we confirmed formation of nanodisperse fine ferrihydrite-like particles. Synthetic analogues these (~ 10 nm hydrodynamic diameter) were readily adherent cell membrane differentiated Caco-2 cells internalization was visualized using transmission...

10.1371/journal.pone.0081250 article EN cc-by PLoS ONE 2013-11-21

The ferritin core is composed of fine nanoparticulate Fe3+ oxohydroxide, and we have developed a synthetic mimetic, polyoxohydroxide (nanoFe3+). aim this study was to determine how dietary iron derived in fashion absorbed the duodenum. Following 4 wk run-in on an Fe-deficient diet, mice with intestinal-specific disruption Fpn-1 gene (Fpn-KO), or littermate wild-type (WT) controls, were supplemented Fe2+ sulfate (FeSO4), nanoFe3+, no added Fe for further wk. A control group sufficient...

10.1096/fj.14-251520 article EN cc-by The FASEB Journal 2014-04-28
David B. Dunger Sylvaine F. A. Bruggraber Adrian Mander M. Loredana Marcovecchio Timothy Tree and 95 more Piotr Jaroslaw Chmura Mikael Knip Anke M. Schulte Chantal Mathieu Chantal Mathieu Pieter Gillard Kristina Casteels Lut Overbergh David B. Dunger Chris Wallace Mark L. Evans Ajay Thankamony E. Hendriks Sylvaine F. A. Bruggraber Mark Peakman Timothy Tree Noel G. Morgan Sarah J. Richardson John A. Todd Linda S. Wicker Adrian Mander Colin Dayan Mohammad Alhadj Ali T. Pieber Décio L. Eizirik M. Cnop Søren Brunak Flemming Pociot Jesper Johannesen Peter Rossing Cristina Legido‐Quigley Roberto Mallone Raphaël Scharfmann Christian Boîtard Mikael Knip Timo Otonkoski Riitta Veijola Riitta Lahesmaa M. Oresic Jorma Toppari Thomas Danne Anette‐Gabriele Ziegler Peter Achenbach T. Rodriguez-Calvo Michele Solimena Ezio Bonifacio Stephan Speier Reinhard W. Holl Francesco Dotta F. Chiarelli P. Marchetti Emanuele Bosi Stefano Cianfarani Paolo Ciampalini Carine de Beaufort Knut Dahl‐Jørgensen Torild Skrivarhaug Geir Joner L. Krogvold Przemysława Jarosz‐Chobot Tadej Battelino B. Thorens Martin Gotthardt Bart O. Roep Tatjana Nikolić Arnaud Zaldumbide Åke Lernmark Markus Lundgren Guillaum Costecalde T. Strube Anke M. Schulte Almut Nitsche Matthias von Herrath Johnna D. Wesley Antonella Napolitano-Rosen Marius Thomas Nanette C. Schloot A. Goldfine Frank Waldron-Lynch J. Kompa A. Vedala N. Hartmann Gwenaelle Nicolas Jean Van Rampelbergh N. Bovy Srijana Dutta John Soderberg Simi Ahmed Frank B. Martin G. Agiostratidou A. Koralova Ruben H. Willemsen Anne Smith Bawani Anand V. Puthi

Abstract Background The INNODIA consortium has established a pan-European infrastructure using validated centres to prospectively evaluate clinical data from individuals with newly diagnosed type 1 diabetes combined centralised collection of samples determine rates decline in beta-cell function and identify novel biomarkers, which could be used for future stratification phase 2 trials. Methods In this context, we have developed Master Protocol, based on the “backbone” natural history study,...

10.1186/s13063-022-06259-z article EN cc-by Trials 2022-05-18

Myo-inositol hexakisphosphate (IP6), is the main iron chelator in cereals and bread. The aim of this study was to investigate effect three commercial baking processes (sourdough, conventional yeast Chorleywood Bread Making Process (CBP)) on IP6 content wholemeal bread, its impact uptake Caco-2 cells predicted bioavailability from these breads with added iron, simulating a mixed-meal. sourdough process fully degraded whilst CBP reduced it by 75% compared flour. released solution after...

10.1016/j.foodchem.2017.01.130 article EN cc-by Food Chemistry 2017-01-28
Tomi Suomi Inna Starskaia Ubaid Ullah Kalim Omid Rasool Maria K. Jaakkola and 95 more Toni Grönroos Tommi Välikangas Caroline Brorsson Gianluca Mazzoni Sylvaine F. A. Bruggraber Lut Overbergh David B. Dunger Mark Peakman Piotr Jaroslaw Chmura Søren Brunak Anke M. Schulte Chantal Mathieu Mikael Knip Riitta Lahesmaa Laura L. Elo Chantal Mathieu Pieter Gillard Kristina Casteels Lutgart Overbergh David B. Dunger Chris Wallace Mark L. Evans Ajay Thankamony Emile Hendriks Sylvaine F. A. Bruggraber Loredana Marcoveccchio Mark Peakman Timothy Tree Noel G. Morgan Sarah J. Richardson John A. Todd Linda S. Wicker Adrian Mander Colin Dayan Mohammad Alhadj Ali Thomas R. Pieber Décio L. Eizirik Myriam Cnop Søren Brunak Flemming Pociot Jesper Johannesen Peter Rossing Cristina Legido‐Quigley Roberto Mallone Raphaël Scharfmann Christian Boîtard Mikael Knip Timo Otonkoski Riitta Veijola Riitta Lahesmaa Matej Orešič Jorma Toppari Thomas Danne Anette G. Ziegler Peter Achenbach Teresa Rodríguez-Calvo Michele Solimena Ezio Bonifacio Stephan Speier Reinhard W. Holl Francesco Dotta Francesco Chiarelli Piero Marchetti Emanuele Bosi Stefano Cianfarani Paolo Ciampalini Carine de Beaufort Knut Dahl‐Jørgensen Torild Skrivarhaug Geir Joner Lars Krogvold Przemysława Jarosz‐Chobot Tadej Battelino Bernard Thorens Martin Gotthardt Bart O. Roep Tatjana Nikolić Arnaud Zaldumbide Åke Lernmark Marcus Lundgren Guillaume Costacalde Thorsten Strube Anke M. Schulte Almut Nitsche Mark Peakman José Luis Vela Matthias von Herrath Johnna D. Wesley Antonella Napolitano-Rosen Mélissa Thomas Nanette C. Schloot Allison B. Goldfine Frank Waldron-Lynch Jill Kompa Aruna Vedala

Type 1 diabetes is a complex heterogenous autoimmune disease without therapeutic interventions available to prevent or reverse the disease. This study aimed identify transcriptional changes associated with progression in patients recent-onset type diabetes.Whole-blood samples were collected as part of INNODIA at baseline and 12 months after diagnosis diabetes. We used linear mixed-effects modelling on RNA-seq data genes age, sex, progression. Cell-type proportions estimated from using...

10.1016/j.ebiom.2023.104625 article EN cc-by EBioMedicine 2023-05-22

There is a growing need for markers that could help indicate the decline in beta cell function and recognise efficacy of intervention type 1 diabetes. Measurements suitably selected serum potentially provide non-invasive easily applicable solution to this challenge. Accordingly, we evaluated broad panel proteins previously associated with diabetes from newly diagnosed individuals during first year diagnosis. To uncover associations function, comparisons were made between these targeted...

10.1007/s00125-023-05974-9 article EN cc-by Diabetologia 2023-08-03

Although the anti-Helicobacter pylori activity of bismuth is well established, therapeutic potential other metal ions against organism not known.We measured minimum inhibitory concentrations a series ions, including several cobalt (II) compounds four type strains and seven clinical isolates H. using three standard broth culture media defined medium. Other intestinal bacteria were also investigated for specificity action.Cobalt chloride had marked (minimum concentration range was 0.03-1.0...

10.1111/j.1083-4389.2004.00264.x article EN Helicobacter 2004-09-09

Type 1 diabetes (T1D) is a chronic autoimmune disease, characterised by progressive destruction of the insulin-producing β cells pancreas. One immunosuppressive agent that has recently shown promise in treatment new-onset T1D subjects aged 12-45 years antithymocyte globulin (ATG), Thymoglobuline, encouraging further exploration lower age groups.Minimal effective low dose (MELD)-ATG phase 2, multicentre, randomised, double-blind, placebo-controlled, multiarm parallel-group trial participants...

10.1136/bmjopen-2021-053669 article EN cc-by BMJ Open 2021-12-01

In the UK contemporary estimates of dietary Fe intakes rely upon food content data from 1980s or before. Moreover, there has been speculation that natural foods fallen over time, predominantly due to changes in agricultural practices. Therefore, we re-analysed common plant-based diet for their (the ‘2000s analyses’) and compared values with most recent published ‘1980s much older ‘1930s analyses’), latter two being different editions McCance Widdowson tables. Overall, was remarkable...

10.1017/s0007114512000360 article EN British Journal Of Nutrition 2012-03-01

Zinc delivery from a nipple shield system (NSDS), novel platform for administering medicines to infants during breastfeeding, was characterised using breastfeeding simulation apparatus. In this study, human milk at flow rates and pressures physiologically representative of passed through the NSDS loaded with zinc-containing rapidly disintegrating tablets, resulting in release zinc into milk. Inductively coupled plasma optical emission spectrometry used detect released, method that does not...

10.1371/journal.pone.0171624 article EN cc-by PLoS ONE 2017-02-03

Fibroblast growth factor 23 (FGF23) is grossly elevated in Gambian children with rickets and, at a lower prevalence, those without bone deformities. We used western blotting to mimic the detection capabilities of C-terminal FGF23 enzyme-linked immunosorbent assay (ELISA). Only intact hormone was present plasma samples from and rickets.Elevated circulating concentrations have been detected using Immutopics ELISA. The ELISA detects both fragment. aim this study determine whether as by were...

10.1007/s00198-012-2029-3 article EN cc-by Osteoporosis International 2012-05-30

Caco-2 cells may be typically used as a first step to investigate the bioavailability of different dietary and fortificant forms iron (Fe) at low levels (&lt; 10 µM) in tissue culture medium (TCM). Whether this model is suitable with supplemental Fe (ca. 200 µM TCM) not clear neither, therefore, choice reference compound under those conditions ‘positive control’. Here we show that ?M TCM (serum-free MEM), Fe(II) sulphate precipitates while high ascorbic acid can prevent this, it detriment...

10.6000/1927-5951.2012.02.01.4 article EN cc-by-nc Journal of Pharmacy and Nutrition Sciences 2012-01-05
Coming Soon ...